Thus, as one might expect, dysregulation of mTOR and its downstream cascades have been shown to play a role in cancer development and progression, with the vast mTOR signaling cascade providing a host of viable therapeutic targets to treat different cancer types [9, 10]. The gene discussed is MTOR; the disease is cancer.